Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical subsidiary Tanabe Mitsubishi Pharma to U.S. private ...

Hillenbrand Inc. has announced plans to sell a 51 percent stake in its Cincinnati-based subsidiary Milacron LLC, to an affiliate of Boston-based investment firm Bain Capital. Hillenbrand, which is ...

Hillenbrand Inc. has announced the sale of a 51 percent stake in its Milacron injection molding and extrusion machinery ...

Key alts deals unveiled today include Silver Point's $250 million CLO fund close, Bain Capital's stake in manufacturer Milacron, a KKR-backed tech acquisition.

Hillenbrand Inc. has announced the sale of a 51% stake in its Milacron injection molding and extrusion business to an ...

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

CEO Hess discussed the company's divestiture of TRANZACT for $632 million, expected to enhance growth, operating margins, and free cash flow starting in 2025. The reentry into the reinsurance market ...